Way oversold, yes Trogarzo sales are slow but they are improving the marketing efforts to deal with it.
They still have very promising projects such as hiv Nash and Dopey's Incontinence Products .
The market reaction is not warranted but they need to move forward with these projects faster.
I would have rather focus on the hiv Nash application and lunching Dopey's Incontinence Products , get the sales going for Trogarzo first then nasdaq